1Mann JF, Gerstein HC, Dulau Florea I, et al. Cardiovascular risk in patients with mild renal insufficiency. Kidney Int Suppl, 2003,84 : S192 - S196.
2Lane JT. Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellims: a temporal perspective. Am J Physiol Renal Physiol, 2004,286 (3) : F442 - F450.
3Parvanova AI, Trevisan R, lliev IP, et al. Insulin resistance and microalbuminuria: a cross - sectional, case - control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes, 2006,55 (5) : 1456 - 1462.
4Orchard TJ, Chang YF, Ferrell RE, et al. Nephropathy in type 1 diabetes., a manifestation of insulin resistance and multiple genetic susceptibilities Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int, 2002,62 (3) :963 - 970.
5Agius E,Attard G, Shakespeare L, et al. Familial factors in diabetic nephropathy: an offspring study. Diabet Med, 2006, 23 (3) :331 - 334.
6Hadjadj S, Duengler F, Torremocha F, et al. Maternal history of type 2 diabetes is associated with diabetic nephropathy in type 1 diabetic patients. Diabetes Metab, 2007,33 (1) : 37 - 43.
7Patari A,Karhapaa P,Taipale H,et al. A 100 - KDa urinary pro-tein is associated with irksulin resistance in offspring of type 2 diabetic patients. Diabetologia, 2005,48 (9) : 1844 - 1850.
8Cha DR, Zhang X, Zhang Y, et al. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. Diabetes, 2007, 56 ( 8 ) : 2036-2045.
10De Cosmo S, Trevisan R, Minenna A, et al. Insulin resistance and the cluster of abnormalities related to the metabolic syndrome are associated with reduced glonaerular filtration rate in
patients with type 2 diabetes. Diabetes Care,2006.29(2) :432 - 434.
